Vitura Health Limited Stock Beta
| VIT Stock | 0.07 0.01 6.25% |
Vitura Health Limited fundamentals help investors to digest information that contributes to Vitura Health's financial success or failures. It also enables traders to predict the movement of Vitura Stock. The fundamental analysis module provides a way to measure Vitura Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vitura Health stock.
Vitura | Beta |
Vitura Health Limited Company Beta Analysis
Vitura Health's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Vitura Health Beta | 0.016 |
Most of Vitura Health's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vitura Health Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Vitura Health Limited has a Beta of 0.016. This is 98.14% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The beta for all Australia stocks is 110.67% lower than that of the firm.
Vitura Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vitura Health's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vitura Health could also be used in its relative valuation, which is a method of valuing Vitura Health by comparing valuation metrics of similar companies.Vitura Health is currently under evaluation in beta category among its peers.
As returns on the market increase, Vitura Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vitura Health is expected to be smaller as well.
Vitura Fundamentals
| Return On Equity | 0.0886 | ||||
| Return On Asset | 0.0515 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 43.3 M | ||||
| Shares Outstanding | 581.65 M | ||||
| Shares Owned By Insiders | 70.64 % | ||||
| Shares Owned By Institutions | 4.02 % | ||||
| Price To Book | 1.12 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 123.87 M | ||||
| Gross Profit | 34.22 M | ||||
| EBITDA | 7.08 M | ||||
| Net Income | 3.51 M | ||||
| Total Debt | 11.02 M | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | 7 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Target Price | 0.7 | ||||
| Beta | 0.016 | ||||
| Market Capitalization | 43.62 M | ||||
| Total Asset | 71.28 M | ||||
| Retained Earnings | 12.67 M | ||||
| Working Capital | 7.61 M | ||||
| Net Asset | 71.28 M |
About Vitura Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vitura Health Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vitura Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vitura Health Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vitura Stock Analysis
When running Vitura Health's price analysis, check to measure Vitura Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitura Health is operating at the current time. Most of Vitura Health's value examination focuses on studying past and present price action to predict the probability of Vitura Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitura Health's price. Additionally, you may evaluate how the addition of Vitura Health to your portfolios can decrease your overall portfolio volatility.